ѰҽÎÊÒ©Íø >> ÕýÎÄ
ÈËÈéÍ·Áö²¡¶¾ÓëÅ®ÐÔÉúÖ³µÀ¼âÈñʪð༰ÑÇÁÙ´²¸ÐȾµÄÑо¿
À´Ô´£ºÑ°Ò½ÎÊÒ©Íø¡¡Ñ°Ò½ÎÊÒ©Íø
µ¥Î»£º130041 ³¤´º°×Çó¶÷Ò½¿Æ´óѧµÚ¶þÁÙ´²Ñ§Ôº¸¾²ú¿Æ
¹Ø¼ü´Ê£º
ÖлªÒ½Ñ§ÔÓÖ¾930920 Å®ÐÔÉúÖ³µÀ¼âÈñʪðà(condyloma acuminata,CA)ÊÇÓÉÈËÈéÍ·Áö²¡¶¾(human papilloma-virus,HPV)ÒýÆðµÄÒ»ÖÖÐÔ´«²¥ÐÔ¼²²¡£¬Æä·¢²¡ÂÊÕýÔÚÖðÄêÉÏÉý¡£È»¶ø£¬Ä¿Ç°¶Ô¸Ã²¡µÄÕï¶Ï½öÏÞÓÚÁÙ´²¹Û²ìºÍ×é֯ѧ¼ì²é£¬ÕâʹһЩÁÙ´²±íÏÖ²»µäÐ͵ĿÉÒɲ¡ÀýÈ·ÕïÀ§ÄÑ¡£ÎÒÃÇÓ¦ÓþۺÏøÁ´·´Ó¦(PCR)¼¼Êõ·Ö±ð¼ì²âÁËʪðà×éÖ¯¡¢¼ÙÐÔʪÅÓ¡¢ÉúÖ³µÀÆäËüÁ¼ÐÔ²¡±äÒÔ¼°Õý³£ÒõµÀ×éÖ¯ÖÐHPV-DNA£¬Í¨¹ý¶Ô CA ²¡ÈËÄÚ¿ã¼°Õý³£ÒõµÀÊÃ× HPV-DNA ¼ì²â£¬Ì½ÌÖ¼âÈñʪðàµÄ´«²¥Í¾¾¶¡£´ËÍ⣬»¹³õ²½¹Û²ìÁ˴Ƽ¤ËØÊÜÌå(estrogen receptor,ER)Óë HPV ¸ÐȾºÍ CA ·¢ÉúµÄ¹ØÏµ¡£
Ò»¡¢²ÄÁϺͷ½·¨
1.²ÄÁÏ£º(1)ÉúÖ³µÀ×éÖ¯ HVP-NDA ¼ì²âÓñ걾ȡ×ÔÏÂÁÐÈËÔ±£ºÁÙ´²±íÏÖµäÐͲ¢¾×é֯ѧ¼ì²é֤ʵµÄ CA57Àý£¬ÁÙ´²±íÏÖ²»µäÐÍ¡¢×é֯ѧ¼ì²éÄÑÒÔÈ·ÕïµÄ¿ÉÒÉ CA21 Àý£¬ÍâÒõ¼ÙÐÔʪÅÓ 47Àý £¬¹¬¾±ÃÓÀà 22 Àý£¬¹¬¾±Ï¢Èâ21Àý£¬ÂýÐÔÒõµÀÑ× 25 Àý£¬ÉúÖ³µÀÕý³£¸¾Å®(È¡ÒõµÀ×éÖ¯)28Àý¡£È¡²ÄÁ¿ 20¡«100mg£¬·ÅÈë Eppendorff ¹ÜÄÚ£¬-40¡æ ±ùÏä±£´æ¡£(2)ÊÃ×Ó HPV-DNA ¼ì²âÓñ걾Ϊ¾ PCR ¼ì²â֤ʵΪ HPV6¡¢11¸ÐȾµÄ 19 Àý CA ²¡È˵ÄÄÚ¿ã(ʹÓÃ2¡«3Ìì)ÊÃ×ÓºÍ50ÃûÕý³£¸¾Å®µÄÒõµÀ±ÚÊÃ×Ó¡£(3)ER ¼ì²âÓÃÍâÒõ×éÖ¯±ê±¾È¡×ÔÏÂÁÐÈËÔ±£º¾×é֯ѧ¼ì²é֤ʵÔÐÆÚÍâÒõ²¿ CA 17Àý£¬·ÇÔÐÆÚÍâÒõ²¿ CA31Àý£¬ÍâÒõÕý³£¸¾Å®11Àý¡£±ê±¾Öà 10% ¼×È©Öй̶¨ºó£¬½øÐÐÃâÒß×黯Ⱦɫ¡£
2.HPV ¹Ñ¾ÛºËÜÕËáÒýÎÓɱ¾ÊÒ×ÔÐÐÉè¼Æ£¬±±¾©¹«°²²¿µÚÆßÑо¿ËùºÏ³É¡£ÓÃÓÚ¼ì²â HPV6¡¢11¡¢16¡¢18µÈ 40 ÓàÖÖ HPV ÐͱðµÄ L1 Çø¹«¹²ÐÍÒýÎï(general primer,GP)¼ò³Æ GP-HPV L1£»ÓÃÓÚ¼ì²â HPV6 ºÍ 11 Ð굀 E6E7 ÇøÐͱðÒýÎï(Type-specific primer,TP)£¬¼ò³Æ TP-HPV(6¡¢11)E6E7¡£Á½¶ÔÒýÎïÀ©ÔöƬ¶Î³¤¶È·Ö±ðΪ 450 ºÍ547 bp¡£
3.³£¹æ×éÖ¯ NDA ÌáÈ¡°´ÎÄÏ×[1]·½·¨½øÐС£
4.PCR¼¼Êõ¡²2¡³£º·ÖΪÒÔ×éÖ¯ DNA ÌáȡҺΪģ°å½øÐеĸ÷ÖÖ×éÖ¯ HPV-DNA ¼ì²âºÍÒÔÖ±½ÓÖó·Ð±äÐÔµÄÊÃ×ÓҺΪģ°å½øÐеĸ÷ÖÖÊÃ×Ó HPV-DNA ¼ì²â£¬·´Ó¦ÌåϵÄÚͬʱº¬ÓÐ GP-HPVVL1 ºÍ TP-HPV(6¡¢11)E6E7Á½¶ÔÒýÎï¡£ÒÔ PBR 322 Hae ¢ó ×÷ DNA ·Ö×ÓÁ¿±ê³ß¡£
5.ER ÃâÒß×éÖ¯»¯Ñ§È¾É«·¨£»²ÉÓà ABC ·¨¡²3¡³±ê¼Ç£¬°ë¶¨Á¿·ÖÎö·¨Åж¨½á¹û¡²4¡³¡£ÒÔÁ×ËỺ³åÒº×ö´Æ¼¤ËØ¿¹ÌåÒõÐÔ¶ÔÕÕ¡£
¶þ¡¢½á¹û
1.×éÖ¯ HPV-DNA ¼ì²â£º±í1£¬Í¼1
±í1 ÉúÖ³µÀ¸÷ÖÖÁ¼ÐÔ²¡±ä¼°Õý³£×éÖ¯ÖÐ HPV-DNA ¼ì³öÇé¿ö ²¡±äÖÖÀà
¼ì²âÀýÊý
GP-HPVL1
TP-HPV(6¡¢11)E6E7
ÑôÐÔÊý
%
ÑôÐÔÊý
%
¼âÈñʪðà
57
56
98
48
86
¼ÙÐÔʪðà
47
19*
40
5*
26
¿ÉÒÉÏ¢Èâ
21
15
21
12
80
¹¬¾±Ï¢Èâ
21
16
76
8
50
¹¬¾±ÃÓÀÃ
22
17
77
3
18
ÂýÐÔÒõµÀÑ×
23
4
16
1
1/4
Õý³£ÒõµÀ×éÖ¯
28
3
11
0
* ÓëÂýÐÔÒõµÀÑ×¼°Õý³£ÒõµÀ×éÖ¯±È£¬¾ùP<0.05
ͼ1 Å®ÐÔÉúÖ³µÀ HPV ¸ÐȾ PCR ¼ì²â½á¹û
2.ÊÃ×Ó HPV-DNA ¼ì²â£º50ÀýÕý³£¸¾Å®ÒõµÀÊÃ×Ó GP-HPVL1 ºÍ TP-HPV(6¡¢11)E6E7ÒõÐÔÂÊ·Ö±ðΪ 54%(27/50)ºÍ7%(2/27)£¬19ÀýÍâÒõ CA ²¡ÈËÄÚ¿ãÊÃ×ÓGP-HPVL1 ºÍ TP-HPV(6¡¢11)E6E7·Ö±ðΪ74%(14/19)ºÍ64%(9/14)£¬Í¼2¡£
ͼ2 Õý³£ÒõµÀÊÃ×Ó HPV-DNA ¼ì²â
3.CA×éÖ¯ÖÐ ER ¼ì²â£ºCA×éÖ¯ÖÐ ER ¼¸ºõÈ«²¿ÑôÐÔ£¬µ«ÔÐÆÚ½Ï·ÇÔÐÆÚ CA µÄ ER ×Åɫǿ¶ÈºÍÑôÐÔϸ°û±ÈÀý¶¼Ç¿ºÍ¸ß£»ÑôÐÔ¿ÅÁ£Ö÷Òª·Ö²¼ÓÚÉÏÆ¤µÄ¿ÅÁ£²ãºÍ¼¬Ï¸°û²ãÉÏ2/3µÄ°ûºËºÍ(»ò)°û½¬ÄÚ¡£Õý³£ÍâÒõ×éÖ¯ÖÐ ER ÑôÐÔºÜÉÙ£¬¼û±í2¡£
±í2 ÍâÒõ²¿ CA ×éÖ¯ ER ¼ì²âÇé¿ö ±ê±¾
¼ì²âÀýÊý
ERÑôÐÔÀýÊý
ר»ÆÉ«¿ÅÁ£(%)
ÑôÐÔϸ°û±ÈÀý(%)
ÔÐÆÚCA
17
17
>80
80¡«96
·ÇÔÐÆÚCA
31
30
<30
22¡«48
Õý³£ÍâÒõ×éÖ¯
11
1
<1
18
Èý¡¢ÌÖÂÛ
½«Á½¶ÔÒýÎïͬʱ¼ÓÈë PCR ·´Ó¦Ìåϵ¾ßÓо¼ÃʡʱµÄÌØµã£¬¿Éͬʱ½øÐÐ HPV ¸ÐȾµÄ¼ì²âºÍ HPV ÐͱðµÄ¼ø¶¨¡£½«ÊÃ×ÓÖ±½ÓÖó·Ð±äÐÔ·Å·ÅÉÏÊöÑ»·ÖУ¬Ê¡ÂÔÁËÊÃ×Ó DNA ÌáÈ¡¹ý³Ì£¬²¢±ÜÃâÁË DNA ³éÌáʱ·ÓµÈÓлúÈÜ»ú¶ÔPCR½á¹ûµÄÓ°Ï죬ÊÊÓÚ HPV ¸ÐȾµÄ´ó·¶Î§ÆÕ²é¡£ÁíÍ⣬±¾×é HPV-DNA ¼ì³öÂÊ˵Ã÷£¬PCR ÊǼì²âCAÖÐ HPV-DNA Ãô¸Ð׼ȷºÍ¿É¿¿µÄ·½·¨£¬¿ÉÃÖ²¹×é֯ѧÕï¶ÏÉϵIJ»×㡲6¡³£¬ÓÈÆäÊÊÓÚ¿ÉÒɲ¡ÀýµÄÈ·Õï¡£
ÒÑÖª¹¬¾±°©µÄ·¢ÉúÓë HPV16 ºÍ 18 Óйأ¬¶ø±¾Ñо¿ÖÐδ²ÉÓà HPV16 ºÍ 18 ÒýÎÒò´Ë£¬HPV-DNA ÑôÐÔ¶ø HPV6 ºÍ 11 ÒõÐԵŬ¾±ÃÓÀò¡Àý²»ÄܳýÍâ HPV16 »ò 18 ¸ÐȾ¡£ÓÉÓÚ´Ó¹¬¾±Á¼ÐÔ²¡±äµ½·ÇµäÐÍÔöÉúÒÔÖÁµ½Ôλ°©ÊÇÒ»¸ö³¤ÆÚÁ¬Ðø¹ý³Ì£¬¹Ê¶Ô´ËÀಡÀýÓ¦ÓèÖØÊÓ¡£±¾×é×ÊÁÏÖУ¬²¡Òò²»Ã÷µÄ¼ÙÐÔʪðà HPV ¼ì³öÂÊËä²»Èç CA ¸ß£¬¸ßÓÚÕý³£ÒõµÀ×éÖ¯ºÍÂýÐÔÒõµÀÑ×(P<0.05)£¬ËµÃ÷¼ÙÐÔʪðàµÄ·¢ÉúÓë HPV ¸ÐȾÓÐÒ»¶¨¹ØÏµ¡£
´Ó CA ²¡ÈËÄÚ¿ãºÍÕý³£¸¾Å®ÓÃÒõµÀÊÃ×ÓÖмì³ö HPV ÌáʾÐÔ½Ó´¥²»ÊÇ CA ´«²¥µÄΨһ;¾¶£¬CA²¡ÈËÎÛȾµÄÄÚ¿ã¿ÉÄÜÊǽ»²æ»ò×ÔÉí´«È¾µÄ´«È¾Ô´£¬Ò²ÊÇ CA ÖÎÁÆÊ§°ÜºÍ¸´·¢µÄÔÒòÖ®Ò»¡£
±¾×é×ÊÁÏÖÐ CA ×éÖ¯ ER ¼¸ºõÈ«²¿ÎªÑôÐÔ£¬ÔÐÆÚ CA µÄÑôÐÔϸ°û±ÈÀýºÍÑôÐÔ¿ÅÁ£Ç¿¶È¶¼¶àÓÚºÍÇ¿ÓÚ·ÇÔÐÆÚ CA¡£ËµÃ÷ CA ÊÇ ER ÒÀÀµ×éÖ¯£¬¶ø ER µÄ·Ö²¼ÌصãÇ¡ºÃÓë×é֯ѧÉϵÄÍÚ¿Õϸ°ûÒÔ¼°ÃâÒß×黯ºÍÔλÔÓ½»ÏÔʾµÄ²¡¶¾¿ÅÁ£´æÔڵIJ¿Î»ÏàÎǺϡ²7£¬8¡³£¬ËµÃ÷´Æ¼¤ËØÊÇ HPV Ö²¡µÄÖØÒª¸¨ÖúÒòËØÖ®Ò»£¬CA µÄ·¢ÉúÓë´Æ¼¤ËØÓйء£
²Î¿¼ÎÄÏ×
1 ¹¨ÊØÁ¼Ö÷±à.ʵÓûù´¡Ò½Ñ§ÊµÑé¼¼Êõ.³¤´º£º¼ªÁÖ¿ÆÑ§³ö°æÉ磬1991¡Ã134.
2 ¹Ø Ó°£¬ÖÜ¿ËÀí£¬·ë´óÁ¦£¬µÈ.ÓÃPCR¼¼Êõ¼ì²â¹¬¾±ÃÓÀú͹¬¾±°©±ê±¾ÖÐ HPV-DNA µÄÑо¿.ÖйúÅ®Ó×±£½¡£¬1992,33¡Ã165.
3 »ÆÖ¾Ó£¬Ó൤Ñô£¬ñÒºê࣬µÈ. ÈËÌåÈéÏÙ°©´Æ¼¤ËغÍÔм¤ËØÊÜÌå¼ì²â75Àý·ÖÎö.Ö×Áö£¬1991,6¡Ã255.
4 Ö£ Ê÷£¬²ÌÐĺ£¬Ã«Ïþ»ª£¬µÈ.ÈËÅßÌ¥×éÖ¯´Æ¼¤ËØÊÜÌå×´¿ö.Öйúҽѧ¿ÆÑ§ÔºÑ§±¨£¬1990,12¡Ã246.
5 Williamson AL,Rybicki EP.Detection of genital human papillomavirus by polymerase chain reaction amplification with degenerated rested primers.J Med Virol,1991,33¡Ã165.
6 Walboomers JM,Melchers WG,Mullin RH.Sensitivity of an in situ detection with biotinylated probes of human papillomevirus type 16 DNA in frezen tissue section of squamous cell carcinoma of the cervix.Am J Pathol,1988,131¡Ã587.
7 Áõ ÎÄ£¬ÀîÖÒÓÓ£¬ÖìÔÂÇ壬µÈ.ÃâÒß×黯·¨¼ìÉúÖ³µÀ²¡±äÖÐÈËÈéÍ·Áö²¡¶¾.ÁÙ´²ÓëʵÑ鲡ÀíѧÔÓÖ¾£¬1991,7¡Ã16.
8 Wilbur DC,Reichman RC,Stoler MH.Detection of infection by human papillomavirus in genital Condylomata.A comparison study using immunocyto chemistry and in situ neucleic acid hybridization. Am J Clin Pathol,1988,89¡Ã505.
(Êո壺1992-12-04 Ð޻أº1993-06-05) (ÎÄÕ³ö´¦£ºÖлªÒ½Ñ§ÔÓÖ¾ 1993ÄêµÚ9ÆÚµÚ73¾í)
ÍÆ¼öÔĶÁ
¼²²¡´óÈ«¸ü¶à>>
½¡¿µÍ¼Æ×
- ÓÑÇéÁ´½Ó